Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication June 19, 2020
- Accepted for publication October 7, 2020
- Published online June 1, 2021.
Article Versions
- previous version (October 30, 2020 - 14:32).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Megan Minnix*,1,2,
- Vikram Adhikarla*,3,
- Enrico Caserta*,4,
- Erasmus Poku5,
- Russell Rockne3,
- John E. Shively1 and
- Flavia Pichiorri4
- 1Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California
- 2Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope, Duarte, California
- 3Department of Computational and Quantitative Medicine, Division of Mathematical Oncology, Beckman Research Institute, City of Hope, Duarte, California
- 4Briskin Myeloma Center and Department of Hematologic Malignancies Research Institute, City of Hope, Duarte, California; and
- 5Radiopharmacy, City of Hope, Duarte, California
- For correspondence or reprints contact: John E. Shively, Beckman Research Institute, City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010. E-mail: jshively{at}coh.org
↵* Contributed equally to this work.
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Targeted Alpha Therapy with [225Ac]Ac-Macropa-Isatuximab for CD38-positive Hematological Malignancies
- Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood Cancers
- Cure of Disseminated Human Lymphoma with [225Ac]Ac-Ofatumumab in a Preclinical Model
- Improved Tumor Responses with Sequential Targeted {alpha}-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice